Japanese pharmaceutical company Eisai, together with Oita University in Japan, has built what could be the world's first AI model that uses data from wearable devices to predict Alzheimer's disease, the most common form of dementia.
Their research team embarked on a study to create a cost-effective, practical tool to pre-screen people suspected of developing the disease. Their findings were...
Harmonic Health, a tech-enabled dementia care platform, announced its launch today alongside a partnership with Stoney Batter Family Medicine, a medical practice with locations in Delaware, Maryland and Pennsylvania.
St. Louis-based Harmonic Health is a company built at Redesign Health, which helps build, launch and find funding for digital health startups.
Harmonic offers comprehensive care-...
A new mobile app developed in Singapore holds promise to prevent the progression of dementia by helping improve the multilingual thinking of senior folks.
HOW IT WORKS
A team of app developers at the Singapore University of Technology and Design (SUTD) has built what could be the world's first multilingual app for dementia prevention, Ami (an acronym for Advancing Mental Invigoration).
Its...
Japanese pharmaceutical company Eisai has established a new digital health business targeting dementia.
WHY IT MATTERS
Eisai's newly formed wholly-owned subsidiary, Theoria Technologies Co., seeks to "accelerate the development of a dementia ecosystem." This ecosystem, according to a press release, will empower people with dementia to "live their fullest lives."
Commencing business in April 2024...
A research project led by researchers from the University of Melbourne will be receiving A$2 million ($1.3 million) in funding and support from Google.org.
The MATCH (Music Attuned Technology - Care via eHealth) project is one of the 15 projects selected for the $25 million AI for the Global Goals grant, which seeks to help organisations accelerate progress towards meeting the United Nation's...
1st Group sells MyHeath1st to HealthShare
ASX-listed 1st Group has sold its human health bookings business to digital health firm HealthShare for A$1.25 million ($830,000).
According to corporate disclosure, 1st Group is divesting its healthcare service search and appointment bookings platform MyHealth1st to plug cash outflows while focusing its capital investments on its other businesses,...
Medical AI company JLK from South Korea has received medical device approval from Food and Drug Administration Thailand for its AI brain image analysis solution.
Founded in 2014, the startup offers a range of image analysis tools under its Medihub platform, which supports the diagnosis of neurological and cancer diseases. It also operates other AI-powered platforms for telehealth, medical...
Fujifilm Corporation has developed AI technology that can predict whether patients with mild cognitive impairment will progress to Alzheimer's disease within two years.
According to a press statement, the AI Technology for AD Progression Prediction has been found to have high generalisability, predicting patients who would progress to AD with high accuracy, even for subjects from different...
SafelyYou, maker of AI-enabled technology for fall detection and prevention, scooped up $30 million in Series B funding months after the close of its $19.5 Series A round.
The round was led by Omega Healthcare Investors, with participation from SCAN Group.
Omega Healthcare Investors, a real estate investment trust that focuses on long term and senior care, also prepaid $10 million to install...
BrainCheck, the company behind a platform that helps assess cognitive impairment, has raised $10 million in Series B funding.
The round was led by Next Coast Ventures and S3 Ventures, with participation from Nueterra Capital, Tensility Ventures and True Wealth Ventures. BrainCheck also secured strategic investment from UPMC Enterprises and SelectQuote.
BrainCheck said the latest round of funding...
def4.jpg "Person answering their front door and getting a delivery from another person")
